Literature DB >> 34046803

Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammation.

Philip M Robson1, Audrey Kaufman2, Alison Pruzan2, Marc R Dweck3, Maria-Giovanna Trivieri2,4, Ronan Abgral5, Nicolas A Karakatsanis2, Patrick M Brunner6, Emma Guttman7, Zahi A Fayad2,4, Venkatesh Mani2.   

Abstract

Non-invasive positron emission tomography (PET) of vascular inflammation and atherosclerotic plaque by identifying increased uptake of 18F-fluordeoxyglucose (18F-FDG) is a powerful tool for monitoring disease activity, progression, and its response to therapy. 18F-FDG PET/computed tomography (PET/CT) of the aorta and carotid arteries has become widely used to assess changes in inflammation in clinical trials. However, the recent advent of hybrid PET/magnetic resonance (PET/MR) scanners has advantages for vascular imaging due to the reduction in radiation exposure and improved soft tissue contrast of MR compared to CT. Important for research and clinical use is an understanding of the scan-rescan repeatability of the PET measurement. While this has been studied for PET/CT, no data is currently available for vascular PET/MR imaging. In this study, we determined the scan-rescan measurement repeatability of 18F-FDG PET/MR in the aorta and carotid arteries was less than 5%, comparable to similar findings for 18F-FDG PET/CT.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Keywords:  18F-FDG; PET/MR; measurement repeatability; scan-rescan; vascular inflammation

Mesh:

Substances:

Year:  2021        PMID: 34046803     DOI: 10.1007/s12350-021-02627-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  32 in total

Review 1.  Concept of vulnerable/unstable plaque.

Authors:  Aloke V Finn; Masataka Nakano; Jagat Narula; Frank D Kolodgie; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07       Impact factor: 8.311

2.  Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.

Authors:  John R Davies; James H F Rudd; Tim D Fryer; Martin J Graves; John C Clark; Peter J Kirkpatrick; Jonathan H Gillard; Elizabeth A Warburton; Peter L Weissberg
Journal:  Stroke       Date:  2005-11-10       Impact factor: 7.914

3.  Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.

Authors:  Minori Mizoguchi; Nobuhiro Tahara; Atsuko Tahara; Yoshikazu Nitta; Norihiro Kodama; Toyoharu Oba; Kazutoshi Mawatari; Hideo Yasukawa; Hayato Kaida; Masatoshi Ishibashi; Naofumi Hayabuchi; Haruhito Harada; Hisao Ikeda; Sho-Ichi Yamagishi; Tsutomu Imaizumi
Journal:  JACC Cardiovasc Imaging       Date:  2011-10

4.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

Authors:  Nobuhiro Tahara; Hisashi Kai; Masatoshi Ishibashi; Hiroyuki Nakaura; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

5.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

Authors:  Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

6.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

7.  Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

Authors:  David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

8.  Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.

Authors:  Artor Niccoli Asabella; Marco M Ciccone; Francesca Cortese; Pietro Scicchitano; Michele Gesualdo; Annapaola Zito; Alessandra Di Palo; Domenico Angiletta; Guido Regina; Andrea Marzullo; Giuseppe Rubini
Journal:  Ann Nucl Med       Date:  2014-04-16       Impact factor: 2.668

9.  Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging: Implications for Vascular Interventional Studies.

Authors:  Fleur M van der Valk; Simone L Verweij; Koos A H Zwinderman; Aart C Strang; Yannick Kaiser; Henk A Marquering; Aart J Nederveen; Erik S G Stroes; Hein J Verberne; James H F Rudd
Journal:  JACC Cardiovasc Imaging       Date:  2016-09-14

10.  Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.

Authors:  Raphaël Duivenvoorden; Venkatesh Mani; Mark Woodward; David Kallend; Gabriela Suchankova; Valentin Fuster; James H F Rudd; Ahmed Tawakol; Michael E Farkouh; Zahi A Fayad
Journal:  JACC Cardiovasc Imaging       Date:  2013-10
View more
  2 in total

1.  Sources of error with cardiovascular PET/CT and PET/MRI and questions to be answered to achieve clinical usefulness.

Authors:  Poul F Høilund-Carlsen; Oke Gerke
Journal:  J Nucl Cardiol       Date:  2021-07-21       Impact factor: 3.872

2.  Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT.

Authors:  Aruki Tanaka; Tetsuro Sekine; Edwin E G W Ter Voert; Konstantinos G Zeimpekis; Gaspar Delso; Felipe de Galiza Barbosa; Geoffrey Warnock; Shin-Ichiro Kumita; Patrick Veit Haibach; Martin Huellner
Journal:  Front Med (Lausanne)       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.